TrialCirculation2022

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.

Ahmed M Shaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.